according to this study , trials will begin in 4 to 6 yrs. it must be the new 5?

http://www.newscientist.com/article/...rkinsons.html?

Living Cell Technologies NTCELL implant shows fast improvement of Parkinson’s symptoms:

http://www.proactiveinvestors.com.au...ms--25785.html

or:

NZ trials planned for Parkinson's therapy:

http://money.msn.co.nz/businessnews/...insons-therapy

I like it Paula, 4 to 6 is the new 5, perhaps it will catch on.

Neil.

[QUOTE=I like it Paula, 4 to 6 is the new 5, perhaps it will catch on.

Neil.[/QUOTE]

New lyrics for old songs department

You do 4 to 6
And what do you get?
Another agonist
And deeper in debt

St. Peter don’t ya call me
‘cause I can’t go.
I’m shakin’ too much
to get up off the floor.

It's always 5 more
To fix PD pain
The rebels call it 4 to 6
But it sounds just the same

You swallow 16 pills
And what do you get?
Addicted to pharma
In Vegas taking bets.
You get really shattered
But what did the doctor expect?
That everything would be solved by sinemet?

Well, my body is weak
But my spirit is strong
I take handfuls of drugs
Just to get along

They say 4 years or 6
But then what do we get?
Another agonist to tweak the sinemet

St. Peter don’t you call me ‘cause I can’t go
I’m sitting here a-shakin right out of control.

New lyrics for old songs department.
This is the song: http://youtu.be/tfp2O9ADwGk

Write your own lyrics and permanently annoy the neighbors!

sixteen studies
what do you get
another day sicker
and deeper in debt

st. peter don't cha call me cause i can't go
i sold my soul to the orgs and drugs show

sixteen trial recruits
and what do they get
reimbursed money
but some deeper regret

st peter don't cha call me cause i can't go
I sold my soul to learn placebo

sixteen people
what do they get
a shot at helping others but deeper pd yet


st. peter don't cha call me cause i can't go
i have to figure out why it's all so slow.

i wait 4 to 6
and what do i derive
that 4 to 6 yrs. just really means 5

st. peter don't cha call me cause i can see
that 4-6 yrs is too many for me.

I have found that business and finance, rather than science, gives a more sober prediction of what's in the pipeline for PD.

In 2007, I jotted down some notes from "Pharmaceutical Business Review":

"The following drugs are expected to do well in the next 10 years:
Novartis's Stalevo
GSK's Requip Modutab
UCB Schwartz's Neupro

"Although cell/gene therapies show great promise, these approaches will not signficantly impact the sale of pharmaceuticals over the period 2007-2016."

i have never used neupro and forget what it is. is it on the market yet?the others cause dyskineisa for me and stalevo is very expensive.Has the price come down any? i was told by my pharmacy the first time i ordered stalevo, i saved more than $600 with insurance.

pharma doesn't need to crunch the numbers about people who improved or who died . that doesn't pay the salaries.

my alprazolam [generic xanax] is less than $8. stalevo $800